Correspondence case reports
The potential dangers of mephedrone in people with diabetes: a case report
Article first published online: 13 JUL 2011
Copyright © 2011 John Wiley & Sons, Ltd.
Drug Testing and Analysis
Special Issue: New Psychoactive Substances
Volume 3, Issue 7-8, pages 464–465, July - August 2011
How to Cite
Wong, M. L. and Holt, R. I. (2011), The potential dangers of mephedrone in people with diabetes: a case report. Drug Test Analysis, 3: 464–465. doi: 10.1002/dta.316
- Issue published online: 20 JUL 2011
- Article first published online: 13 JUL 2011
Mephedrone is a cathinone derivative that has been used as a ‘legal high’ but was re-classified in the UK as a class B (intermediate category) drug. This report describes an 18-year-old man with type 1 diabetes who developed ketoacidosis following self-reported mephedrone use. Cathinone compounds may directly increase the risk of diabetic ketoacidosis by stimulating the central nervous system but may also indirectly impair an individual's ability to manage their diabetes through changes in cognitive function and behaviour.